Pharmacology and clinical experience with simvastatin

Expert Opinion on Pharmacotherapy
D C Hess, S C Fagan

Abstract

Simvastatin (Zocortrade mark, Merck) is a safe and effective 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. Simvastatin potently lowers total and low density lipoprotein (LDL) cholesterol. Simvastatin was the first cholesterol-lowering agent that reduced total mortality in a randomised clinical trial. Simvastatin is effective at reducing total mortality, myocardial infarction, coronary mortality and the incidence of stroke or transient ischemic attack in patients with coronary heart disease and hypercholesterolemia. Simvastatin, like other statins, also has non-lipid mechanisms of action. These include anti-inflammatory effects, antiproliferative effects on smooth muscle cells and an upregulation of endothelial nitric oxide synthase. Overall, simvastatin has an excellent safety profile. Simvastatin, along with other statins, has made a significant impact on the morbidity and mortality from coronary heart disease.

References

Nov 1, 1991·The American Journal of Cardiology·S J BoccuzziM E Keegan
Jan 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·H J KempenL M Havekes
Jul 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·Y SaitoY Goto
Apr 4, 1986·Science·M S Brown, J L Goldstein
May 28, 1987·The New England Journal of Medicine·S GlagovG J Kolettis
Aug 1, 1995·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·W R Garnett
Aug 1, 1995·Circulation·E FalkV Fuster
Feb 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·A NotarbartoloC Patrono
Feb 23, 1995·The New England Journal of Medicine·G N LevineJ A Vita
Mar 1, 1993·Clinical Pharmacokinetics·V F Mauro
Feb 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·S ColliE Tremoli
Nov 22, 1997·Stroke; a Journal of Cerebral Circulation·N Delanty, C J Vaughan
Feb 19, 1998·The American Journal of Cardiology·T R PedersenT Haghfelt
Jun 5, 1998·JAMA : the Journal of the American Medical Association·R S Rosenson, C C Tangney
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M EndresJ K Liao
Aug 7, 1998·Atherosclerosis·S BellostaA Corsini
Sep 16, 1998·The American Journal of Cardiology·M Farnier, J Davignon
Nov 13, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·S BellostaF Bernini
Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Jan 14, 1999·The New England Journal of Medicine·R Ross
Jan 20, 1999·Circulation·C D Furberg
Feb 23, 1999·European Journal of Clinical Pharmacology·U JeppesenS H Sindrup
Jul 2, 1999·Stroke; a Journal of Cerebral Circulation·G A LammieM S Dennis
Jun 24, 2000·JAMA : the Journal of the American Medical Association·C R MeierH Jick
Aug 3, 2000·The New England Journal of Medicine·H D WhiteA M Tonkin
Jan 1, 1994·Trends in Cardiovascular Medicine·L L DemerK Boström

❮ Previous
Next ❯

Citations

Mar 8, 2005·Survey of Ophthalmology·Robyn Heather GuymerPaul Nigel Baird
Mar 19, 2005·The Journal of Clinical Investigation·Liyan ZhuangMichael R Freeman
Jan 20, 2007·Journal of Neuroinflammation·Clive BateAlun Williams
Aug 7, 2009·The Journal of Nutrition, Health & Aging·G OnderF Landi
Jul 23, 2009·Expert Review of Anti-infective Therapy·Marcus W BrazierSteven J Collins
Apr 10, 2007·Experimental Eye Research·Nina SagaraHidenobu Tanihara
Aug 3, 2017·Journal of Lipid Research·Véronique PerrierCatherine Desrumaux
Sep 29, 2018·The Journal of Clinical Endocrinology and Metabolism·Aura D Herrera-MartínezRaúl M Luque
May 15, 2007·Neuroreport·Sarah KempsterAlun Williams
Jan 25, 2008·Environmental Toxicology·Peter B KeyMichael H Fulton
May 1, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Farhad R Danesh, Yashpal S Kanwar
Apr 15, 2009·Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes·Peter B KeyMichael H Fulton

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

The New England Journal of Medicine
Burton T Blackman
Expert Opinion on Pharmacotherapy
A S Wierzbicki
Science's STKE : Signal Transduction Knowledge Environment
M Edidin
© 2021 Meta ULC. All rights reserved